Kronox Lab Sciences Limited, established in 2008, is a public limited company specializing in the production of High Purity Speciality Fine and Inorganic Chemicals. Initially focused on serving the pharmaceutical and nutraceutical industries, the company has expanded its manufacturing capabilities to cater to solar, biotech, agrochemical, personal care, and metal refinery sectors, among others. Their chemicals are crucial as reacting agents, excipients, and process intermediates in various applications such as Active Pharmaceutical Ingredients (APIs), laboratory research, and animal health products.
The company operates two manufacturing units, with Unit I established in 2009 and expanded in subsequent years, and Unit II commencing operations in 2015. Kronox Lab Sciences is planning an Initial Public Offering (IPO) to raise Rs 45 crore through a fresh issue and an additional 78,00,000 equity shares through an Offer for Sale, indicating its growth ambitions and focus on expanding its market presence.
